Results 81 to 90 of about 2,965,429 (175)

Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation

open access: yesCardiology Research and Practice, 2019
Study hypothesis. We sought to investigate the association between echocardiographic optimisation and ventricular activation time in cardiac resynchronisation therapy (CRT) patients, obtained through the use of electrocardiographic mapping (ECM).
Helder Pereira   +11 more
doaj   +1 more source

Advanced Conduction Disease After Incident Heart Failure in Myotonic Dystrophy Type 1

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Central Figure. Advanced Conduction Disease After Incident HF in Myotonic Dystrophy Type 1. ABSTRACT Background Myotonic dystrophy type 1 (DM1) is associated with progressive cardiac conduction disease, heart failure (HF) and increased mortality. However, the association of incident HF with conduction disease and survival in DM1 is not well defined ...
Isadora Guarino   +3 more
wiley   +1 more source

CARDIAC RESYNCHRONISATION THERAPY: SELECTED PATHOPHYSIOLOGICAL ASPECTS OF DYSSYNCHRONY AND HEMODYNAMIC DISTURBANCES

open access: yesРоссийский кардиологический журнал, 2012
Management of chronic heart failure (CHF) remains one of the most important problems in modern cardiology. Despite the recent pharmacotherapy successes, substantial numbers of CHF patients remain resistant to pharmaceutical treatment.
M. V. Kiyutina   +3 more
doaj  

“Real world” experience in cardiac resynchronisation therapy at a Swiss tertiary care centre: update 2016

open access: yesSwiss Medical Weekly, 2017
BACKGROUND Based on a reduction in morbidity and mortality, cardiac resynchronisation therapy (CRT) has evolved as a standard therapy for patients with advanced heart failure.
Stephan Winnik   +17 more
doaj   +1 more source

A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi   +14 more
wiley   +1 more source

Safety of Pulsed Field Ablation: Established Evidence, Emerging Risks, and Knowledge Gaps

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Overview of the safety profile of pulsed field ablation (PFA), highlighting established safety advantages, procedure‐related complications, electroporation‐specific effects, and key areas of ongoing uncertainty, particularly for ventricular applications.
Dakota de Cecco   +3 more
wiley   +1 more source

Treatment of chronic heart failure by the use of resynchronization therapy

open access: yesZdravniški Vestnik, 2005
: Chronic heart failure due to systolic dysfunction has been treated pharmacologically by the extensive use of ACE inhibitors, beta blockers, spyronolactone and digoksin improving morbidity, mortality and the quality of life as well as decreasing ...
Borut Geršak   +4 more
doaj  

Panoramic voltage‐sensitive optical mapping of contracting hearts using cooperative multiview motion tracking with 12 cameras

open access: yesThe Journal of Physiology, EarlyView.
Abstact figure legend A panoramic 3D optical mapping system was developed, enabling imaging of action potential waves across the entire strongly deforming ventricular surface of beating isolated hearts. The system comprises 12 high‐speed cameras and a soccerball‐shaped imaging chamber with 48 light‐emitting diodes (LEDs).
Shrey Chowdhary   +5 more
wiley   +1 more source

Non-pharmacological treatment of heart failure: Implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy [PDF]

open access: yes, 2006
The non-pharmacological therapy of heart failure, in particular an implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy or biventricular stimulation, improves symptoms and survival in patients with heart failure. - An ICD is
Nieuwland, W   +3 more
core   +4 more sources

A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care

open access: yesHealth Services and Delivery Research, 2016
Background: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms,
Holly Standing   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy